更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
生物科技CEO们致信马卡里,呼吁FDA保持稳定,称波动性威胁美国创新
Hundreds of industry leaders have signed a letter to FDA Director Marty Makary, M.D., about the importance of having a predictable regulatory agency, citing a survey in...
Illumina CEO薛睿德:立足“在中国,为中国”以科技推动中国医疗健康新篇章——财新全球
Illumina CEO Jacob Thaysen: Anchoring “In China, For China” to Drive a New Chapter in China’s Healthcare Through Technology Caixin Global
安捷伦科技(NYSE:A)CEO减持911股股票——MarketBeat报道
Insider Selling: Agilent Technologies (NYSE:A) CEO Sells 911 Shares of Stock MarketBeat
杰夫·布鲁斯通与斯蒂芬·迪利探讨CEO交接及索诺玛未来走向;斯科特·戈特利布的下一步动向
Endpoints News sat down with Jeff Bluestone and Stephen Dilly after Sonoma Biotherapeutics announced earlier this week that Bluestone was stepping down from his CEO rol...
Illumina CEO表示对找到与中国长期解决方案持乐观态度——彭博社报道
'Hopeful' We'll Find Long-term Solution On China: Illumina CEO Bloomberg.com
Illumina三季度在华遇阻致销售持平,CEO称与相关机构保持沟通——Fierce Biotech报道
Illumina sales flat in Q3 amid China headwinds as CEO remains 'in dialogue' with agencies Fierce Biotech
罗氏CEO称正就药品定价与美国政府持续磋商——医药科技
Roche in ongoing discussions with US government over drug pricing, CEO says Pharmaceutical Technology
罗氏CEO及制药高管将就美国关税问题与瑞士政府会晤——路透社
Roche CEO, pharma execs to meet with Swiss government over US tariffs Reuters
Illumina CEO展望稳定增长之路,尽管学术客户面临资金不确定性
Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty statnews.com
罗氏CEO称正考虑直接向美国患者销售药品——路透社
Roche considering selling drugs directly to US patients, CEO says Reuters
前Cytiva首席执行官Emmanuel Ligner执掌Avantor:30年行业资深人士引领增长 - 股票巨头
Former Cytiva CEO Emmanuel Ligner Takes Helm at Avantor: 30-Year Industry Veteran to Drive Growth Stock Titan
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页